Biotech

All Articles

2 cancer biotechs combine, making worldwide impact

.OncoC4 is actually taking AcroImmune-- and also its in-house professional production abilities-- un...

Amgen documents first stage 3 win for $400M dermatitis drug

.Amgen has actually discussed (PDF) the 1st stage 3 records on its own $400 thousand eczema medicati...

Biogen, UCB record phase 3 lupus win after neglecting earlier trial

.Biogen and also UCB's bet one's bottom dollar advancing in to stage 3 astride a failed research wan...

Aptadir really hopes new RNA preventions can easily reverse tricky cancers

.Italian biotech Aptadir Rehabs has launched with the promise that its pipeline of preclinical RNA i...

Wave surfs DMD excellence to regulatory authorities' doors, delivering stock up

.Wave Life Sciences has fulfilled its goal in a Duchenne muscular dystrophy (DMD) study, installing ...

Sanofi tweezes brand new CSO coming from in-stealth biotech

.After a couple of years in biotech, Mike Quigley, Ph.D., is actually returning to the pharma layer,...

Achilles trickles cell treatment course, supports for discharges after missing 'business stability' targets

.Achilles Therapies has actually torn up its own tactic. The English biotech is actually knocking of...

Aligos heralds period 2 MASH win, slashing liver body fat up to 46%

.Aligos Therapies is declaring a midstage succeed in metabolic-dysfunction associated steatohepatiti...

Basilea ratings $268M BARDA financing for antifungals, prescription antibiotics

.Basilea Pharmaceutica's job developing new antifungals has actually received a substantial increase...

Capricor sells Europe liberties to late-stage DMD treatment for $35M

.Having currently gathered up the USA civil liberties to Capricor Therapies' late-stage Duchenne mus...